ÃÀ¸ß÷
ÓªÒµ×Éѯ
Öйú£º
Email: marketing@medicilon.com.cn
ÓªÒµ×ÉѯרÏߣº400-780-8018
£¨½öÏÞЧÀÍ×Éѯ£¬£¬£¬£¬ÆäËûÊÂÒËÇ벦´ò´¨É³×ܲ¿µç»°£©
´¨É³×ܲ¿µç»°: +86 (21) 5859-1500
ÍâÑó£º
+1(781)535-1428(U.S.)
0044 7790 816 954 (Europe)
Email:marketing@medicilon.com




1. 8ÔÂ29ÈÕ£¬£¬£¬£¬¼ÎÒëÉúÎïÒ½Ò©£¨º¼ÖÝ£©ÓÐÏÞ¹«Ë¾Ðû²¼£¬£¬£¬£¬Æä×ÔÖ÷Ñз¢µÄºôÎüµÀºÏ°û²¡¶¾£¨RSV£©mRNAÒßÃ磨NT-INF-001£© Õýʽ»ñµÃ¹ú¼ÒÒ©Æ·¼àÊÓ¹ÜÀí¾ÖÒ©Æ·ÉóÆÀÖÐÐÄ£¨CDE£©Åú׼ǩ·¢µÄ¡¶Ò©ÎïÁÙ´²ÊÔÑéÅú׼֪ͨÊé¡·¡£¡£¡£¡£
2. 9ÔÂ1ÈÕ£¬£¬£¬£¬Ê¯ËÄÒ©¼¯ÍÅÐû²¼Í¨¸æ³Æ£¬£¬£¬£¬ÆäÎÚÀµØ¶û»ºÊͽºÄÒ¼°ÑÎËáÄῨµØÆ½ÂÈ»¯ÄÆ×¢ÉäÒºÒÑÈ¡µÃÖйú¹ú¼ÒÒ©Æ·¼àÊÓ¹ÜÀí¾ÖµÄÒ©Æ·Éú²ú×¢²áÅú¼þ¡£¡£¡£¡£ÕâÁ½¿î»¯Ñ§Ò©Æ·µÚ3Àà»ñÅú£¬£¬£¬£¬ÊÓͬͨ¹ýÒ»ÖÂÐÔÆÀ¼Û£¬£¬£¬£¬ÇÒ¾ùΪº£ÄÚÆóÒµÖÐÊ×¼Ò»ñÅúµÄ²úÆ·¡£¡£¡£¡£
3. 8ÔÂ29ÈÕ£¬£¬£¬£¬ÈÕ±¾ÎÀ²Ä¹«Ë¾ºÍÃÀ¹ú²³½¡¹«Ë¾Ðû²¼£¬£¬£¬£¬ÃÀ¹úFDA£¨ÃÀ¹úʳÎïÒ©Æ·¼àÊÓ¹ÜÀí¾Ö£©ÒÑÅú׼ÿÖÜÒ»´ÎµÄÂØ¿¨Ä¹Æ¤ÏÂ×Ô¶¯×¢É䣨SC-AI£©ÖÜά³Ö¼ÁÁ¿ÉÏÊУ¬£¬£¬£¬ÓÃÓÚÖÎÁÆÔçÆÚ°¢¶û´Äº£Ä¬²¡£¡£¡£¡£¨AD£©¡£¡£¡£¡£
4. 8ÔÂ28ÈÕ£¬£¬£¬£¬¿µÕÜÒ©ÒµÆìϵÂþҽҩÁ¬Í¬ÆäÁ¥Êô¹«Ë¾ÓÚ8ÔÂ28ÈÕÊÕµ½Ò©ÎïÁÙ´²ÊÔÑéÅú׼֪ͨÊé¡£¡£¡£¡£NMPAÔ޳ɿªÕ¹povorcitinib£¨Öƶ©ÖÐÎÄͨÓÃÃû£ºÁ×Ëá²´ÎÖÎôÌæÄáÆ¬£©ÓÃÓڷǽڶÎÐͰ×ñ°·çºÍÖÐÖØ¶È»¯Å§ÐÔº¹ÏÙÑ×£¨HS£©µÄÁÙ´²ÊÔÑé¡£¡£¡£¡£
1. 8ÔÂ31ÈÕ£¬£¬£¬£¬Å·ÁÖÉúÎïͨ¸æ£¬£¬£¬£¬¹«Ë¾ÄâÒÔ×Ô³ï×ʽðÊÕ¹º³É¶¼ÉúÎï³ÇÒ»ºÅ¹ÉȨͶ×Ê»ù½ðºÏ×ÊÆóÒµ£¨ÓÐÏÞºÏ×Ê£©¡¢³É¶¼ÉúÎï³Çݼ´´¹ÉȨͶ×Ê»ù½ðºÏ×ÊÆóÒµ£¨ÓÐÏÞºÏ×Ê£©ºÏ¼Æ³ÖÓеĹ«Ë¾¿Ø¹É×Ó¹«Ë¾³É¶¼ÐÂŵÃ÷ÉúÎï¿Æ¼¼ÓÐÏÞ¹«Ë¾15%µÄ¹ÉȨ¡£¡£¡£¡£
1. 8ÔÂ29ÈÕ£¬£¬£¬£¬Ç廪´óѧÃâÒßѧÑо¿ËùÅíÃôÍŶÓÔÚ Nature ×Ó¿¯ Nature Communications ÉϽÒÏþÁËÌâΪ£ºGD2TIF cells as a platform for single-dose and long-term delivery of biologics µÄÑо¿ÂÛÎÄ¡£¡£¡£¡£¸ÃÑо¿¿ª·¢Á˳¤ÊÙÃü CAR-T ϸ°û×÷ΪһÖÖÐÂÐÍÒ©ÎïÌåÄÚµÝËÍÆ½Ì¨£¬£¬£¬£¬¸Ã³¤ÊÙÃü CAR-T ϸ°ûÔÚ¶¯ÎïÄ£×ÓÖÐʵÏÖÁË·ÊÅÖºÍÌÇÄò²¡ÖÎÁÆÒ©Îï GLP-1 µÄºã¾ÃÎȹ̵ÝËÍ£¬£¬£¬£¬Ö»Ðèµ¥´ÎÊäÈë¼´¿Éά³Ö·ÊÅÖºÍÌÇÄò²¡µÄºã¾Ã»º½â£¬£¬£¬£¬ÎªÐèÒªÖÕÉíÖÎÁƵÄÂýÐÔ¼²²¡ÌṩÁËÖÎÓúµÄDZÔÚ¿ÉÄÜÐÔ¡£¡£¡£¡£
[1]Zhang, G., Yin, N. & Peng, M. GD2TIF cells as a platform for single-dose and long-term delivery of biologics. Nat Commun 16, 8088 (2025).
Ïà¹ØÐÂÎÅ